Back
The Goldman Sachs Group Vs. Corcept Therapeutics Industry Stock Comparison
Buy
65
GS
The Goldman Sachs Group
Last Price:
504.11
Seasonality Move:
4.42%
Buy
68
CORT
Corcept Therapeutics
Last Price:
40.92
Seasonality Move:
-0.77%
Buy
65
The Goldman Sachs Group (GS)
is a Buy
Is The Goldman Sachs Group a Buy, Sell or Hold?
- The current The Goldman Sachs Group [GS] share price is $484.58. The Score for GS is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- GS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
68
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy, Sell or Hold?
- The current Corcept Therapeutics [CORT] share price is $42.27. The Score for CORT is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- CORT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GS Stock Price Chart
What is The Goldman Sachs Group's stock price today?
-
The The Goldman Sachs Group share price today is $484.58
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GS is experiencing slight selling pressure.
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $42.27
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing slight buying pressure.
GS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.99 | Sell |
Relative Strength Index (14 RSI): | 48.12 | Sell |
Chaikin Money Flow: | -741680 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (480.54 - 505.62) | Sell |
Bollinger Bands (100): | (450.32 - 493.96) | Buy |
CORT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.36 | Buy |
Relative Strength Index (14 RSI): | 82.3 | Buy |
Chaikin Money Flow: | 670376 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.47 - 37.45) | Buy |
Bollinger Bands (100): | (28.16 - 35.86) | Buy |
GS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 479.38 | Buy |
20-day SMA: | 491.15 | Sell |
50-day SMA: | 490.48 | Sell |
200-day SMA: | 429.92 | Buy |
8-day EMA: | 482.92 | Buy |
20-day EMA: | 486.76 | Sell |
50-day EMA: | 484.13 | Buy |
200-day EMA: | 437.14 | Buy |
CORT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 37.44 | Buy |
20-day SMA: | 35.75 | Buy |
50-day SMA: | 34.88 | Buy |
200-day SMA: | 28.43 | Buy |
8-day EMA: | 38.24 | Buy |
20-day EMA: | 36.43 | Buy |
50-day EMA: | 34.68 | Buy |
200-day EMA: | 30.05 | Buy |
The Goldman Sachs Group Earnings Growth & GS Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.81 per share, an increase next quarter of $1.79 per share, an increase this year of $14.19 per share, and an increase next year of $4.16 per share.
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.15 per share, an increase this year of $0.22 per share, and an increase next year of $0.59 per share.
The Goldman Sachs Group Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Corcept Therapeutics Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |